Evidence map›Paper›PMID 42417988›Full record

ArticleSocial psychiatry and psychiatric epidemiology2026

Exploring the association between maternal attention-deficit/hyperactivity disorder and obstetric complications: a danish population-based register study.

Mette Winther, Rikke Damkjaer Maimburg, Sarah Kittel-Schneider, Louise Bøttcher, Kathrine Bang Madsen

Abstract read
PubMed Publisher
In one paragraph

Article in Social psychiatry and psychiatric epidemiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mette WintherDepartment of Educational anthropology and Educational psychology, Danish School of Education, Aarhus University, Jens Chr. Skous Vej 4, 8000, Aarhus, Denmark. mewin@edu.au.dk.ORCID http://orcid.org/0009-0004-9790-1610
Rikke Damkjaer MaimburgDepartment of Midwifery, University College of Northern Denmark, Selma Lagerløfsvej 2, Aalborg Ø, 9220, Denmark.
Sarah Kittel-SchneiderPsychiatric and Psychotherapeutic Hospital, University Hospital Erlangen, Friedrich-Alexander-University, Erlangen-Nuremberg, Schwabachanlage 6, 91054 , Erlangen, Germany.
Louise BøttcherDepartment of Educational anthropology and Educational psychology, Danish School of Education, Aarhus University, Jens Chr. Skous Vej 4, 8000, Aarhus, Denmark.
Kathrine Bang MadsenResearch Unit of Child and Adolescent Psychiatry, Odense UniversityMental Health Services in the Region of Southern Denmark, Odense, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeMaternal attention-deficit/hyperactivity disorder (ADHD) is increasingly recognised during the reproductive years, often with delayed diagnosis. Although ADHD has been linked to perinatal complications, it remains unclear whether risks reflect ADHD itself, comorbidity, vulnerability, behaviours, and medication use. We examined associations between maternal ADHD, stratified by diagnosis before and after childbirth, and ADHD medication exposure during pregnancy with a range of pregnancy, childbirth, and neonatal outcomes.

methodsWe conducted a nationwide register-based cohort study, including 741,905 singleton live births in Denmark (2010-2022). Childbirths were classified by maternal ADHD diagnosis before childbirth (n = 12,859), after childbirth (n = 15,683), and no ADHD (n = 713,363). Among women diagnosed before childbirth, ADHD medication exposure was classified; no exposure (n = 10,118), first-trimester (n = 1,129) and continued (n = 1,612) based on prescription-timing. Analyses were preformed using Poisson GEE, accounting for repeated births and adjusting for sociodemographics, psychiatric history, and somatic comorbidity.

resultsMaternal ADHD diagnosed before childbirth was associated with preterm childbirth (aRR 1.13, 95% CI 1.04-1.22; aRR 1.29, 95% CI 1.07-1.56) and low birthweight (aRR 1.19, 95% CI 1.09-1.30). Early pregnancy haemorrhage was modestly elevated for ADHD diagnosed before and after childbirth (aRR 1.15, 95% CI 1.08-1.25; aRR 1.14, 95% CI 1.07-1.22). ADHD diagnosed after childbirth was associated with infection (aRR 1.19, 95% CI 1.11-1.27), hyperemesis (aRR 1.23, 95% CI 1.13-1.34), and Apgar score < 7) (moderate aRR 1.48, 95% CI 1.09-2.01; severe aRR 1.32, 95% CI 1.09-1.59). ADHD medication in pregnancy (vs. unmedicated) was associated with gestational hypertension (first-trimester aRR 1.57, 95% CI 1.21-2.02; continued aRR 1.39, 95% CI 1.01-1.91).

conclusionMaternal ADHD, whether diagnosed before childbirth or postpartum, was associated with small increases in selected obstetric and neonatal risks after adjustment for relevant sociodemographic and clinical factors. Continued use of ADHD medication was significantly associated with gestational hypertension only. However, these findings should be interpreted with caution due to the potential for residual confounding, including confounding by indication.

Indexed as

ADHD medication|Attention Deficit Disorder with HyperactivityObstetricsPpregnancy outcomePregnancy complications

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.